We classified the gastric cancer patients into 3 categories based on the p53 mutation status as well as the DNA methylation status of PGP9. 5, NMDAR2B and CCNA1, which we designated as genomic and epigenetic categories, respectively (GEC). Here, GRIN2B is linked to gastric cancer.